Zevra Therapeutics Inc (ZVRA) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Zevra Therapeutics Inc   (NASDAQ: ZVRA)
 

Zevra Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Zevra Therapeutics Inc 's inventory turnover ratio sequentially decreased to 2.82 in the third quarter 2026, unsurprisingly, as the Zevra Therapeutics Inc markets continue to deteriorate, and ZVRA's faces growing challenges to bring down its inventories. Zevra Therapeutics Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 129 days, from 40 days, in the Jun 30 2026 quarter.

Within Healthcare sector 144 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. 344.

ZVRA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Zevra Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZVRA Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 124.58 % 121.03 % -9.73 % -11.68 % -
Y / Y Cost of Sales Growth -86.13 % -87.68 % 41.04 % 11.27 % 200.67 %
Inventory Turnover Ratio (TTM) 2.82 9.09 17.61 16.64 16.01
ZVRA's Total Ranking # 344 # 344 # 272 # 244 #
Average inventory processing period 130 40 21 22 23
Seq. Inventory Growth 25.36 % 6.02 % 32.76 % 27.29 % 23.38 %
Seq. Cost of Sales Growth 17.64 % -19.61 % 24.8 % -88.25 % 4.52 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 36
Healthcare Sector # 145
Overall Market # 344

Inventory Turnover Ratio Statistics
High Average Low
17.61 12.43 2.82
(Mar 31 2026)   (Sep 30 2026)



ZVRA Company Profile >> Back to ZVRA Efficiency Comparisons >> Compare ZVRA Inventory Turnover Ratio to its Competitors

Financial Statements
Zevra Therapeutics Inc 's Inventories $ 3 Millions Visit ZVRA's Balance sheet
Zevra Therapeutics Inc 's Cost of Revenues TTM $ 7 Millions Visit ZVRA's Income Statement
What are ZVRA's Sales? Visit ZVRA's Sales by Segment

Other Inventory Turnover Ratios
Zevra Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ZVRA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ZVRA's Competitors
Inventory Turnover Ratio for ZVRA's Suppliers
Inventory Turnover Ratio for ZVRA's Customers

You may also want to know
ZVRA's Sales Growth Rates ZVRA's Pe Price to earnings ratio ZVRA's Receivables Turnover Ratio ZVRA's Stock Quote
ZVRA's Net Income Growth Rates ZVRA's Ps Price to Sales ratio ZVRA's Sales per Employee ZVRA's Asset Turnover Ratio
ZVRA's Net Margin ZVRA's Pb Price to Book ratio ZVRA's Financial Strength Ratios ZVRA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Lifemd Inc   4.89 $ 23.534  Millions$ 5  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Beyond Air Inc   4.65 $ 6.574  Millions$ 1  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Elite Pharmaceuticals Inc   3.48 $ 80.918  Millions$ 23  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions

Date modified: 2026-11-06T12:58:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.